Earnings season: Macquarie names 3 ASX stocks to buy that report this week

Here are the broker's top picks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As we move further into earnings season, Macquarie Group Ltd (ASX: MQG) has listed its three most-preferred ASX stocks. All three will announce their financial results this week.

A man with a wide, eager smile on his face holds up three fingers.

Image source: Getty Images

An earnings season preview

In a note to investors this morning, the broker said that share price reactions have been relatively positive so far. It also expects that earnings results do not suggest another momentum reversal in August. 

"Earnings updates leading into results have been relatively positive in terms of the share price reactions. Of 9 updates we collated, 4 outperformed (HLO, PNV, DRO, MHJ) and 2 underperformed (FLT, VEA)", the broker said.

Macquarie added that so far, there has been a normal reaction to surprises. It explained:

February's results were marked by a momentum reversal that was evident in the early results. The recent market reactions show no such reversal. Stocks are moving in reaction to the positive/negative surprise in a more normal way.

In [June], we highlighted our momentum framework helped in positioning for earnings risks. In our Results Outlook (28 Jul 2025), we showed the approach also worked in US results. Over July, Stage 1 (bottoming) stocks have the best average relative return (+2.8%) after posting an earnings update, while also having modest upgrades to FY25 earnings (+0.6%). In contrast, Stage 4 stocks have the largest average underperformance (-2.3%) and the largest downgrades FY25 downgrades (-7.9%).

Macquarie's three most-preferred ASX stocks

Pinnacle Investment Management Group Ltd (ASX: PNI) is Macquarie's key buy idea for the week. 

This morning, the PNI share price is in the green, changing hands at $22.59 a piece, up 2.78%. 

Over the past month, the PNI share price is 9.56% higher, and is up 43.55% for the year.

Macquarie has an outperform rating and a $25.10 target price. At the time of writing, this represents a potential 11.1% upside for investors over the next 12 months.

"PNI is the key buy idea for Week 1, as it is rated Outperform, has momentum in Stage 1 and the Street has been upgrading FY26 earnings", the broker said in its note.

PNI is due to announce its results this afternoon.

QBE Insurance Group Ltd (ASX: QBE) is another of Macquarie's top picks for the week.

The QBE share price is also in the green this morning, trading 0.8% higher at $22.63 at the time of writing. Over the past month, QBE's share price is down 0.62%, but over the year, it is 37.14% higher.

Macquarie has a neutral rating on the stock and a $23.20 target price. At the time of writing, that represents a potential 2.5% upside for investors over the next 12 months.

QBE is expected to announce its results on Friday this week.

Centuria Industrial REIT (ASX: CIP) is also one of Macquarie's most preferred stocks for the earnings season.

At the time of writing, the CIP share price is 0.16% higher for the day, and changing hands at $3.185 a piece. Over the past month, CIP shares have gained 1.43%, and over the year, they are 3.91% higher.

Macquarie has a neutral rating on the stock and a $3.22 12-month target price. At the time of writing, that represents a potential 1.1% upside for investors.

"While rated Neutral, we also note QBE and CIP have momentum in Stage 2, plus FY26 upgrades", the broker said.

CIP is expected to announce its results on Friday.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Pinnacle Investment Management Group. The Motley Fool Australia has positions in and has recommended Macquarie Group and Pinnacle Investment Management Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX share tips from 4 brokers, for returns better than 40%

These shares are ripe for a re-rating the analysts say.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

2 ASX mining shares to sell: experts

Experts say it's time to sell these ASX mining shares after an impressive run in FY26.

Read more »

A man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
Broker Notes

Buy, hold, sell: Weebit Nano, Metals X, Pro Medicus shares

We review three fresh buy, hold, and sell calls from expert market analysts.

Read more »

Young boy with glasses in a suit sits at a chair and reads a newspaper.
Broker Notes

Sell Judo shares and 2 other ASX small caps: experts

ASX small-cap shares outperformed the broader market in FY26, but experts are calling time on these 3 stocks. Here's why.

Read more »

A young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Broker Notes

Buy, hold, sell: SKS Technologies, Yancoal, Wesfarmers shares

Let's check out some new ratings on ASX shares today.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Wisetech Global, CBA shares

Experts explain their ratings on 3 ASX 200 shares. 

Read more »

A female athlete in green spandex leaps from one cliff edge to another.
Broker Notes

Up 149% in a year, why this surging ASX 300 tech stock is still a good buy today

One expert weighs in.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Broker Notes

Up 75%, are Pro Medicus shares still a good buy now?

A leading analyst provides his forecast for Pro Medicus shares.

Read more »